1763

China Isotope & Radiation Corporation (1763)

Market Closed
15 Dec, 08:00
HKEX HKEX
20. 54
HKD
-0.56
-2.65%
HKD
7.09B Market Cap
- P/E Ratio
0.35% Div Yield
159,000 Volume
- Eps
21.1 HKD
Previous Close
Day Range
20.52 21.1
Year Range
10 25
Want to track 1763 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1763 closed today lower at 20.54 HKD, a decrease of 2.65% from yesterday's close, completing a monthly decrease of -3.66% or 0.78 HKD. Over the past 12 months, 1763 stock gained 89.83%.
The next announced payment will be in In 2 weeks on Dec 31, 2025 for a total of 0.08817 HKD.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

1763 Chart

Similar

Carsgen Therapeutics Holdings Limited
15.05 HKD
-3.53%
Beijing Biostar Pharmaceuticals, Co., Ltd.
3.25 HKD
+10.54%
Aim Vaccine Co. Ltd.
3.4 HKD
-3.13%
CK Life Sciences Int'l.,
0.84 HKD
0%
Tyk Medicines Inc.
13.14 HKD
+0.08%

China Isotope & Radiation Corporation (1763) FAQ

What is the stock price today?

The current price is 20.54 HKD.

On which exchange is it traded?

China Isotope & Radiation Corporation is listed on HKEX.

What is its stock symbol?

The ticker symbol is 1763.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.35%.

What is its market cap?

As of today, the market cap is 7.09B.

Has China Isotope & Radiation Corporation ever had a stock split?

No, there has never been a stock split.

China Isotope & Radiation Corporation Profile

Health Care Technology Industry
Healthcare Sector
- CEO
HKEX Exchange
- ISIN
China Country
3,361 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Founded in 1983 and headquartered in Beijing, China, China Isotope & Radiation Corporation (CIRC) operates at the forefront of the nuclear medicine and irradiation service industries in China. As a crucial subsidiary of China National Nuclear Corporation, CIRC harnesses nuclear technology to improve healthcare and industrial processes through its comprehensive portfolio of products and services. The company's operations are segmented into five main areas: Pharmaceuticals, Radioactive Source Products, Irradiation, Radiation Therapy Equipment and Related Services, and Independent Clinical Medical and Laboratory Services and Other Businesses. Through its diversified segments, CIRC is committed to advancing research, development, manufacture, and sale of radiopharmaceuticals for diagnostic and therapeutic applications, offering sterile irradiation services for various industries, and supplying cutting-edge radiation therapy equipment. The company's dedication to innovation, quality, and safety drives its contributions to medical science and various industrial domains.

Products and Services

  • Imaging Diagnostic and Therapeutic Radiopharmaceuticals:

    These products are developed for the diagnosis and treatment of various diseases, utilizing the latest advances in nuclear medicine technology. CIRC's diverse range of radiopharmaceuticals includes agents for PET and SPECT imaging, offering precise images of the body’s internal structure and function to guide diagnoses and therapeutic decisions.

  • UBT Kits and Analyzers:

    Specialized in diagnostic applications, the Urea Breath Test (UBT) kits and analyzers provided by CIRC are designed for the detection of Helicobacter pylori infection, a common cause of peptic ulcers and gastritis. This non-invasive diagnostic method enhances patient comfort and diagnostic efficiency.

  • In Vitro Immunoassay Diagnostic Reagents and Kits:

    These products are used for the detection and quantification of specific antigens or antibodies in samples, serving a crucial role in the diagnosis of various conditions. CIRC’s immunoassay products leverage advanced technologies to ensure high sensitivity and specificity.

  • Medical and Industrial Radioactive Source Products:

    Providing a range of radioactive source products and related technical services for both medical and industrial applications. These include sources for cancer therapy, non-destructive testing, and for use in research and development activities.

  • Irradiation Services:

    CIRC offers sterilization irradiation services for medical devices, food, traditional Chinese medicine, and cosmetics, employing gamma rays and other irradiation methods. The company also provides EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities, contributing to safer medical and consumer products.

  • Radiation Therapy Equipment and Related Services:

    This segment encompasses the sale and maintenance of advanced radiation therapy equipment for cancer treatment, including after-sale support. CIRC leverages cutting-edge technology to offer effective solutions for oncological care.

  • Independent Clinical Laboratory Services:

    Offering laboratory services that utilize nuclear technology for various industrial applications and medical product analysis. This includes providing comprehensive clinical tests and analyses to support the healthcare and nuclear industries.

Contact Information

Address: No. 66 Changwa Middle Street
Phone: 86 10 6851 5220